| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MALLINCKRODT PUB LTD CO SHS | 1,560,157 | 94,826,000 | 13.42% | ||
| 2 | MEDIVATION INC | 1,270,000 | 76,581,000 | 10.84% | ||
| 3 | ARIAD PHARMACEUTICALS INC | 8,845,742 | 65,370,000 | 9.25% | ||
| 4 | IRONWOOD PHARMACEUTICALS INC COM CL A | 4,929,139 | 64,448,000 | 9.12% | ||
| 5 | ORTHOFIX INTERNATIONAL NV | 1,224,496 | 51,919,000 | 7.35% | ||
| 6 | RETROPHIN INC COM | 2,699,947 | 48,086,000 | 6.81% | ||
| 7 | ANI PHARMACEUTICALS INC COM | 817,456 | 45,630,000 | 6.46% | ||
| 8 | DEPOMED INC | 2,275,300 | 44,641,000 | 6.32% | ||
| 9 | UNITED THERAPEUTICS | 418,700 | 44,349,000 | 6.28% | ||
| 10 | PENUMBRA INC COM | 684,079 | 40,703,000 | 5.76% | ||
| 11 | CLOVIS ONCOLOGY INC | 2,936,487 | 40,289,000 | 5.70% | ||
| 12 | EAGLE PHARMACEUTICALS INC COM | 482,047 | 18,699,000 | 2.65% | ||
| 13 | NXSTAGE MED INC COM | 835,134 | 18,106,000 | 2.56% | ||
| 14 | CEPHEID | 453,662 | 13,950,000 | 1.97% | ||
| 15 | NUVASIVE INC COM | 165,203 | 9,866,000 | 1.40% | ||
| 16 | PACIFIC BIOSCIENCES CALIF IN | 1,114,448 | 7,840,000 | 1.11% | ||
| 17 | ADMA BIOLOGICS, INC. | 1,273,933 | 7,580,000 | 1.07% | ||
| 18 | VERICEL CORP | 2,232,940 | 5,024,000 | 0.71% | ||
| 19 | AXOGEN INC | 526,351 | 3,621,000 | 0.51% | ||
| 20 | SEASPINE HLDGS CORP COM | 255,334 | 2,676,000 | 0.38% | ||
| 21 | BIOLASE INC | 1,257,292 | 1,471,000 | 0.21% | ||
| 22 | VERACYTE INC | 165,825 | 834,000 | 0.12% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-16-004292, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
